Eiman Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-07-2024
- Paid Up Capital ₹ 0.10 M
as on 24-07-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 55.15%
(FY 2023)
- Profit 149.24%
(FY 2023)
- Ebitda 427.84%
(FY 2023)
- Net Worth 37.04%
(FY 2023)
- Total Assets 118.41%
(FY 2023)
About Eiman Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Ranjan and Romana Khan serve as directors at the Company.
- CIN/LLPIN
U85310UP2016PTC084991
- Company No.
084991
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Noida, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eiman Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Ranjan  | Director | 19-Jul-2016 | Current |
| Romana Khan | Director | 16-Aug-2016 | Current |
Financial Performance of Eiman Pharma.
Eiman Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.15% increase. The company also saw a substantial improvement in profitability, with a 149.24% increase in profit. The company's net worth Soared by an impressive increase of 37.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eiman Pharma?
In 2023, Eiman Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eiman Pharma?
Unlock and access historical data on people associated with Eiman Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eiman Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eiman Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
